HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CV 3988

platelet activating factor antagonist; structure given in first source
Also Known As:
2-methoxy-3-(octadecylcarbamoyloxy)propyl-2-(3-thiazolinium) ethyl phosphate; 3-(N-n-octadecylcarbamoyloxy)-2-methoxypropyl-2-thiazolinium ethyl phosphate; 3-MOTP; CV-3988; CV3988; Thiazolium, 3-(4-hydroxy-7-methoxy-10-oxo-3,5,9-trioxa-11-aza-4-phosphanonacos-1-yl)-, hydroxide, inner salt, P-oxide, (+-)-
Networked: 46 relevant articles (2 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Ebina, Keiichi: 1 article (09/2017)
2. Sato, Akira: 1 article (09/2017)
3. Andujar, Pascal: 1 article (02/2016)
4. Antonini, James M: 1 article (02/2016)
5. Brown, Jeremy: 1 article (02/2016)
6. Cohignac, Vanessa: 1 article (02/2016)
7. Erdely, Aaron: 1 article (02/2016)
8. Grigg, Jonathan: 1 article (02/2016)
9. Jose, Ricardo J: 1 article (02/2016)
10. Lanone, Sophie: 1 article (02/2016)

Related Diseases

1. Inflammation (Inflammations)
2. Silicosis
3. Shock
4. Nephritis
5. Hypotension (Low Blood Pressure)

Related Drugs and Biologics

1. ginkgolide B
2. Loratadine (Alavert)
3. Silicon Dioxide (Silica)
4. Histamine H1 Antagonists
5. rupatadine
6. pirfenidone
7. Platelet Activating Factor
8. CV 6209
9. Dinoprostone (PGE2)
10. Endotoxins

Related Therapies and Procedures

1. Intravenous Administration
2. Catheters
3. Therapeutics
4. Surgical Instruments (Clip)
5. Intradermal Injections